Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | PKM2 |
| Upstream (Parents) |
|---|
| (<<) PHLDA2 → PKM2 |
| (<<) C7orf44 → PKM2 |
| (<<) ALDOA → PKM2 |
| (<<) MAFF → PKM2 |
| Downstream (Children) |
|---|
| PKM2 → SLC28A3 (>>) |
| PKM2 → FUT8 (>>) |
| PKM2 → TSPAN5 (>>) |
| PKM2 → LOC29034 (>>) |
| PKM2 → KIAA1199 (>>) |
| PKM2 → TTC9 (>>) |
| PKM2 → SLC2A1 (>>) |
| PKM2 → ENO2 (>>) |
| PKM2 → MLANA (>>) |
| PKM2 → ULBP2 (>>) |
| PKM2 → IL23A (>>) |
| PKM2 → LOC650293///UNC93B4///UNC93B2///LOC442381///OR7E125P///OR7E37P///OR7E87P (>>) |
| PKM2 → HOXB7 (>>) |
| PKM2 → PMAIP1 (>>) |
| PKM2 → FOSL2 (>>) |
| PKM2 → FAM57A (>>) |
| PKM2 → NAAA (>>) |
| PKM2 → VPS37B (>>) |
| PKM2 → MAPK8IP1 (>>) |
| PKM2 → C7orf44 (>>) |
| PKM2 → ALDOA (>>) |
| PKM2 → FHL2 (>>) |
| PKM2 → DDIT4 (>>) |
| PKM2 → TGFBI (>>) |
| PKM2 → CDC42EP3 (>>) |
| PKM2 → MICALL1 (>>) |
| PKM2 → PPP1R14B (>>) |
| PKM2 → NT5DC2 (>>) |
| PKM2 → G6PD (>>) |
| PKM2 → CLCN5 (>>) |
| PKM2 → PLXNA1 (>>) |
| PKM2 → MYBPC3 (>>) |
| PKM2 → CASS4 (>>) |
| PKM2 → SMTN (>>) |
| PKM2 → ST7L (>>) |
| PKM2 → RTN2 (>>) |
